Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05296668
Other study ID # MD-62-2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date December 19, 2023

Study information

Verified date December 2023
Source Kasr El Aini Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This thesis aims to assess the safety and efficacy of usage of cuffed ETT in neonate undergoing elective surgeries.


Description:

Neonates will be recruited into the trial during pre-operative assessment. Recruited neonates will be randomly assigned to one of two groups in a 1:1 ratio; (group C) to receive a cuffed ETT and (group U) to receive an uncuffed ETT for airway management. Randomization will be achieved using a computer-generated sequence. Concealment will be achieved using opaque envelopes. All neonates will be anesthetized in accordance with the local policy of pediatric anesthesia unit in Abu El-Reesh pediatric hospital-Cairo university after ethics committee approval. After preoperative examination and upon arrival to the operating room heart rate, noninvasive blood pressure NBP and oxygen saturation SPO2 will be monitored using standard monitor (drȁger infinity vista XL) before inhalational induction of anesthesia using titration of sevoflurane in oxygen air mixture 60% (starting from 3% up to 8%) until the neonate is put to sleep. Baseline lung ultrasound will then be done. After securing an intravenous line anesthesia will be completed with 1-2µg/kg of fentanyl and atracurium 0.5 mg/kg. Induction of anesthesia will be performed by the attending senior anesthesia resident who has finished at least 2 years of residency (who is independent of the study team). (Microcuff®, Halyard Health Inc., Atlanta, GA, USA), will be chosen for cuffed TTs, and (Mallinckrodt® Contour Murphy Eye) for non-cuffed tubes. The appropriate ETT size will be decided by the attending anesthesia resident and will be based on the absence of resistance to insertion of the tube and the presence of audible leak (with inflation pressures of 20 cmH2O following initial cuff deflation for the cuffed ETT group). As necessary, ETT sizes will be adjusted one size up or down to achieve these conditions starting from 3mm internal diameter size. For both groups: intubation trials will not exceed 2 times, or it will be excluded from the study. Following inflation of the ETT cuff in C group, pressure will be measured using cuff manometry (Portex Limited, Hythe, Kent, UK) with cuff pressures will be monitored continuously, and if necessary, adjusted to pressures ≤ 20 cmH2O to allow for a good cuff seal without hyperinflation of the cuff. Measurements will be carried out under both volume- controlled ventilation (VCV) and pressure-controlled ventilation (PCV) using (G.E-Datex-Ohmeda, Avance CS2, USA). Ventilation will be set initially to VCV of 6 ml/kg and PEEP 3 cmH2O. three anesthesia workstation measurements of inspiratory and expiratory tidal volumes will be recorded, and the mean taken for analysis of leakage around the ETT. Ventilation will then be adjusted to PCV of 10 cmH2O, PEEP of 3 cmH2O and leakage around the tube analyzed again in the same way. Then these measurements will be done again at 10 min and 20 min. Once these measurements are taken, ventilation will be continued as VCV of 6-8 ml/kg, PEEP 3 cmH2O and respiratory rate will be set between 30-40 to maintain end tidal CO2 within 30-40 mmHg for the remainder of the case. At the end of the procedure and before return of spontaneous ventilation another set of measurements will be recorded. In both groups, after return of spontaneous ventilation the neonates will be put on pressure support PS mode (PS 10, PEEP 3 and flow trigger of 1 L/min) and when the neonate is capable of triggering at least 70% of his own breathes and has good motor power; the ETT will be removed by the attending anesthetist after reversal of muscle relaxant effect using neostigmine 0.05 mg/kg with atropine 0.02 mg/kg and timing of extubation will be recorded. All patients will be transported to the post anesthesia care unit PACU after ensuring that their airway and oxygenation are adequate. Oxygen saturation will be measured continuously until discharge from the PACU. Oxygen saturation will be recorded when the neonates are calm and the pulse oximeter showing consistent detection. Lowest measured SpO2 values will be recorded 10 min before removal of the ETT, and at 1 min, 5 min, 10 min, 15 min, 20 min and 30 min after removal. Any respiratory adverse events (laryngospasm; bronchospasm; desaturation < 95%; airway obstruction; severe coughing and/or postoperative stridor) as well as subsequent interventions will be recorded and managed according to the local policy of Abo El Reesh pediatric hospital. All postoperative measurements will be collected by PACU nurse who is independent of the study team.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 19, 2023
Est. primary completion date December 19, 2023
Accepts healthy volunteers No
Gender All
Age group 1 Day to 1 Month
Eligibility Inclusion Criteria: - • Neonates (infant in the first 28 days after birth) - Full term (more than 37 gestational weeks) - More than 3 kg bodyweight - ASA I-II - Scheduled for elective surgeries under general anesthesia requiring endotracheal intubation. Exclusion Criteria: - • Parents or legally authorized personnel refusal. - Anatomical abnormalities of upper air way. - Emergency surgery. - Low birth weight less than 3 kg - Surgery longer than 2 hours - Premature neonates - Upper airway surgery - Requirement for postoperative ventilation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cuffed ETT (Microcuff®, Halyard Health Inc., Atlanta, GA, USA)
(group C) to receive a cuffed ETT for airway management.
Uncuffed ETT group
(group U) to receive an uncuffed ETT for airway management.

Locations

Country Name City State
Egypt Kasralainy Cairo

Sponsors (1)

Lead Sponsor Collaborator
Kasr El Aini Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of ETT exchange to find the appropriate ETT the incidence of ETT exchange to find the appropriate ETT defined as:(the absence of resistance to insertion of the tube and the presence of audible leak with inflation pressures of 20 cmH2O). 2 hours
Secondary Duration of intubation calculated from time from the introduction of the laryngoscope blade to the mouth till the first trace of capnography recorded. 10 minutes
Secondary Leakage around the ETT defined as the mean of three readings of difference between inspiratory and expiratory tidal volumes (as measured by the anesthesia machine) at T0: after intubation, T1: immediately after recruitment, T2: 10 min after recruitment, T3: 20 min after recruitment, T4: at the end of surgery. 2 hours
Secondary Number of attempts to insert and correctly size the tracheal tube. Number of attempts to insert and correctly size the tracheal tube. 10 minutes
Secondary Desaturation incidence (SPO2 less than 95%) at 1 min, 5 min, 10 min, 15 min, 20 min and 30 min postoperatively. 30 minutes postoperative
Secondary Hoarseness of voice. Hoarseness of voice. Graded as follow:
0= no hoarseness (good high-pitched cry sound)
mild hoarseness (good cry but soft whispering low-pitched sound)
severe hoarseness (cry but no audible sound)
30 minutes postoperative
Secondary Croup incidence Croup (defined as triad of barking cough, stridor and a hoarse voice). 30 minutes postoperative
See also
  Status Clinical Trial Phase
Completed NCT00951860 - Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort N/A
Recruiting NCT05601375 - Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally
Terminated NCT04025021 - Targeted Breast Milk Fortification for Very Low Birth Weight Infants in the NICU N/A
Recruiting NCT05965830 - Comparing Electromyography of the Diaphragm With Ultrasound in Neonates and Children With Respiratory Support
Completed NCT04904965 - Frontal Electroencephalography of Neonatal Patients Under Sedation With Opioids and General Anesthesia With Propofol. N/A
Recruiting NCT05835817 - Magnetoencephalography by Optical Pumping Magnetometer N/A
Recruiting NCT04905732 - Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD N/A
Completed NCT04794881 - Repeat Lumbar Puncture at 24 Versus 48 Hours After Traumatic Lumbar Puncture in Neonates N/A
Recruiting NCT04795453 - Assessment of Score System of Surgery in Necrotizing Enterocolitis(NEC) Patients
Completed NCT03103022 - Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus Phase 1
Completed NCT05197868 - Applied Forces During Neonatal Intubation N/A
Withdrawn NCT05045092 - A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China
Withdrawn NCT05075486 - Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support N/A
Withdrawn NCT05085080 - Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS)
Recruiting NCT05181423 - Identification of Noninvasive Biomarkers for Neonates Undergoing Abdominal Surgery
Completed NCT05104255 - Neonatal Outcomes in Twin Pregnancies
Completed NCT03082001 - Sucrose to Reduce Pain During Initiation of Venipuncture in Extremely Low Birth Weight Babies Phase 3
Not yet recruiting NCT05934682 - Latin American Surgical Outcomes Study in Pediatric Patients
Completed NCT04937348 - Visfatin and Omentin-1 - Markers of Nutritional Status of Newborns Born to Diabetic Mothers.
Completed NCT04464057 - Safety and Effectiveness of Early Feeding After Bowel Anastomosis in Neonates or Infants N/A